|
Re: You're right 10bagr, you didn't sway me....
|
1
|
Resverlogix Corp.
|
Feb 02, 2019 05:34PM
|
|
Re: K2
|
1
|
Resverlogix Corp.
|
Apr 10, 2021 09:33AM
|
|
Re: Additional Reports Of Exempt Distribution.
|
1
|
Zenith Epigenetics
|
Jun 05, 2024 08:46PM
|
|
Re: Short interest still dropping - down 6+ %
|
1
|
Resverlogix Corp.
|
Oct 10, 2024 06:27PM
|
|
Re: Partnership?
|
1
|
Resverlogix Corp.
|
Jun 22, 2020 02:06PM
|
|
Re: Another big night/day for Hepa
|
1
|
Resverlogix Corp.
|
May 06, 2024 09:23AM
|
|
LINK for the AGM
|
1
|
Resverlogix Corp.
|
Jun 21, 2022 02:56PM
|
|
Re: If BP buys Apabetalone,...
|
1
|
Resverlogix Corp.
|
Nov 05, 2019 04:30PM
|
|
Re: Link for tomorrow morning late breaker results
|
1
|
Resverlogix Corp.
|
Nov 15, 2019 03:30PM
|
|
Re: Zenith and Newsoara Biopharma Announce Expanded Licensing and Investment.
|
1
|
Zenith Epigenetics
|
Nov 17, 2021 06:16PM
|
|
Re: Market Woes
|
1
|
Resverlogix Corp.
|
Apr 30, 2022 07:42PM
|
|
Clinical trials query results
|
1
|
Zenith Epigenetics
|
Apr 08, 2021 09:27AM
|
|
Re: Finance
|
1
|
Resverlogix Corp.
|
May 26, 2020 06:30PM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
1
|
Zenith Epigenetics
|
Apr 24, 2022 11:14AM
|
|
Re: RESVERLOGIX CORP. Annual And Special Meeting: December 22, 2020
|
1
|
Resverlogix Corp.
|
Nov 25, 2020 11:48AM
|
|
Re: Technical strength versus fundamental weakness....
|
1
|
Resverlogix Corp.
|
Mar 31, 2019 07:48PM
|
|
Re: Received a response....Third Eye Loan Balance-Updated
|
1
|
Resverlogix Corp.
|
Jul 16, 2019 06:18PM
|
|
Re: Aducanumab and the amyloid beta hypothesis is not dead yet!
|
1
|
BIOASIS TECHNOLOGIES INC
|
Oct 23, 2019 12:32PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
1
|
Resverlogix Corp.
|
Mar 24, 2020 04:10PM
|
|
Re: As Pfizer charges ahead....
|
1
|
Resverlogix Corp.
|
Sep 04, 2021 08:19AM
|
